Literature DB >> 33096349

Microcirculation alterations in severe COVID-19 pneumonia.

Vanina Siham Kanoore Edul1, Juan Francisco Caminos Eguillor2, Gonzalo Ferrara3, Elisa Estenssoro2, Daniel Shiovan Páez Siles4, Cristián Emanuel Cesio3, Arnaldo Dubin5.   

Abstract

PURPOSE: To assess the presence of sublingual microcirculatory and skin perfusion alterations in COVID-19 pneumonia.
MATERIALS AND METHODS: This is a preliminary report of a prospective observational study performed in four teaching intensive care units. We studied 27 mechanically ventilated patients with acute respiratory distress syndrome secondary to COVID-19. Sublingual microcirculation was assessed by hand-held videomicroscopy. A software-assisted analysis of videos was performed. We also measured capillary refill time.
RESULTS: Patients were hemodynamically stable with normal lactate (1.8 [1.6-2.5] mmol/L) and high D-dimer (1.30 [0.58-2.93] μg/mL). Capillary refill time was prolonged (3.5 [3.0-5.0] s). Compared to previously reported normal values, total and perfused vascular density (21.9 ± 3.9 and 21.0 ± 3.5 mm/mm2) and heterogeneity flow index (0.91 ± 0.24) were high; and the proportion of perfused vessels (0.96 ± 0.03), microvascular flow index (2.79 ± 0.10), and red blood cell velocity (1124 ± 161 μm/s) were reduced. The proportion of perfused vessels was inversely correlated with total vascular density (Pearson r = -0.41, P = 0.03).
CONCLUSIONS: COVID-19 patients showed an altered tissue perfusion. Sublingual microcirculation was characterized by decreases in the proportion of perfused vessel and flow velocity along with high vascular densities. This last finding might be related to enhanced angiogenesis or hypoxia-induced capillary recruitment.
Copyright © 2020. Published by Elsevier Inc.

Entities:  

Keywords:  COVID-19; Capillary refill time; Microcirculation; Pneumonia

Year:  2020        PMID: 33096349      PMCID: PMC7568145          DOI: 10.1016/j.jcrc.2020.10.002

Source DB:  PubMed          Journal:  J Crit Care        ISSN: 0883-9441            Impact factor:   3.425


Introduction

Microvascular thrombosis has recently been diagnosed in patients with COVID-19, and it has been proposed to mediate the pathogenesis of organ injury in this disease [1]. While widespread pulmonary microvascular thrombosis was demonstrated [2], reports about the compromise of extrapulmonary microvessels are inconsistent. Some anatomopathological reports found extrapulmonary microvascular thrombosis, but others failed to show such alterations [3,4]. Recently, sublingual microcirculatory abnormalities were shown in 12 patients with COVID-19 pneumonia [5]. Since microvascular densities were inversely correlated with D-dimer levels, these abnormalities might have resulted from microthrombosis. A growing body of evidence suggests that the microvascular disorder plays a role in the pathogenesis of septic shock and is related to outcome [6]. Thus, our goal was to assess the characteristics of sublingual microcirculation and skin perfusion in patients with acute respiratory distress syndrome (ARDS) secondary to COVID-19. In this report, we show the preliminary results of a prospective multicenter study.

Materials and methods

We included 27 patients with diagnosis of ARDS secondary to COVID-19 (positive result by polymerase chain reaction testing of nasopharyngeal or tracheal samples), from 4 intensive care units (ICU) in Argentina. All patients were intubated and mechanically ventilated, received infusions of midazolam, fentanyl and atracurium, and anticoagulant prophylaxis from their hospital admission. No patient had superinfections at the moment of the study. Blood pressure, heart rate and norepinephrine infusion remained unchanged for 3-h before the measurements. Sublingual microcirculation was assessed by means of hand-held videomicroscopy, within the first 3 days of ICU admission. Relevant aspects of video acquisition and software-assisted analysis are described elsewhere [6]. Several videos were taken in each patient. Based on the total microcirculation image quality score, the best three videos were selected for analysis [7]. Analysis was focused on small microvessels (diameter < 20 μm) whereas large microvessels were only considered for ruling out compression artifacts. For the calculation of proportion of perfused vessels and perfused vascular density, we took into account microvessels with continuous and sluggish flow. Capillary refill time was measured by applying firm pressure to the ventral surface of the right index finger distal phalanx with a glass microscope slide. The pressure was increased until the skin was blank and maintained for 10 s. The time for return of the normal skin color was registered with a chronometer, and a refill time greater than 3 s was defined as abnormal. The respective institutional review boards approved this study and waived patient informed consent. We present continuous variables as median (interquartile range [IQR]) or mean ± SD, and categorical variables as numbers and percentages. Values of COVID-19 patients were compared with those of healthy volunteers from a previous study.by unpaired t-test [6]. Analyses were performed using Stata version 15 (StataCorp).

Results

Main clinical and laboratory characteristics of the patients are shown in Table 1 . Norepinephrine (0.03 [0.01–0.17] μg/kg/min) was required in 12 patients (44%). The fluid balance in the previous 24-h was 600 [100-1490] mL. D-dimer and ferritin levels were elevated (Table 1). Median plasma lactate was normal (1.8 [1.6–2.5] mmol/L). Capillary refill time was prolonged (3.5 [3.0–5.0] s).
Table 1

Clinical and laboratory characteristics of the patients.

CharacteristicValue
Age, y60 [51–63]
Female gender, No. (%)7 (26)
APACHE II score12 [9–17]
SOFA score6 [3–8]
Dead, No. (%)9 (33)
Discharged alive, No. (%)3 (11)
Remained in hospital, No. (%)15 (56)
Mean arterial pressure, mm Hg76 ± 9
Heart rate, beats/min86 ± 26
Positive end-expiratory pressure, cm H2O11 ± 2
Arterial pH7.31 ± 0.05
Arterial PCO2, mmHg45 ± 8
Arterial PO2, mmHg90 ± 27
Hemoglobin, g/dL11.7 ± 2.1
PaO2:FiO2 ratio (normal values > 400)122 ± 43
White blood cell count, ×109/L (reference range = 3.8–10.5 × 109/L)11.0 ± 4.6
Lymphocyte blood cell count, ×109/L (reference range = 1.0–3.3 × 109/L)0.80 ± 0.04
International normalized ratio (reference range = 0.8–1.2)1.1 ± 0.1
Activated partial thromboplastin time, s (reference range = 23–36 s)369
Platelet count, ×103/μL (reference range = 150–450)235 ± 111
D-dimer, μg/mL (reference range < 0.50 μg/mL)1.30 [0.58–2.93]
Ferritin, ng/mL (reference range = 15–400 ng/mL)593 [454–1162]

Data are shown as number (%), median [IQR] or mean ± SD.

Abbreviations: APACHE II, Acute Physiology and Chronic Health Evaluation; SOFA, Sequential Organ Failure Assessment.

Clinical and laboratory characteristics of the patients. Data are shown as number (%), median [IQR] or mean ± SD. Abbreviations: APACHE II, Acute Physiology and Chronic Health Evaluation; SOFA, Sequential Organ Failure Assessment. The total microcirculation image quality score was 1 [0-2] [7]. Compared to reported normal values [6], total and perfused vascular density and heterogeneity flow index were high; and the proportion of perfused vessels, microvascular flow index, and red blood cell velocity were reduced (Table 2 ). The proportion of perfused vessels was inversely correlated with total vascular density (Pearson r = −0.41, P = 0.03). D-dimer levels were not correlated with either total or perfused vascular density (Pearson r = −0.12, P = 0.59 and Pearson r = −0.12, P = 0.57, respectively). Total and perfused vascular density were correlated with capillary refill time (Pearson r = −0.43, P = 0.02 for both).
Table 2

Sublingual microcirculatory variables.

VariableValueNormal valuesP-value
Total vascular density (mm/mm2)21.9 ± 3.916.7 ± 1.6<0.0001
Perfused vascular density (mm/mm2)21.0 ± 3.516.6 ± 1.6<0.0001
Proportion of perfused vessels0.96 ± 0.031.00 ± 0.00<0.0001
Microvascular flow index2.79 ± 0.102.97 ± 0.03<0.0001
Red blood cell velocity (μm/s)1124 ± 1611331 ± 190<0.0001
Heterogeneity flow index0.91 ± 0.240.04 ± 0.03<0.0001
Sublingual microcirculatory variables.

Discussion

This is one of the few characterizations of sublingual microcirculation in patients with COVID-19 pneumonia. Our patients had moderate-to-severe ARDS and high levels of D-dimer, as biochemical evidence of intravascular coagulation and increased fibrinolysis. Although most of them were hemodynamically stable, they had alterations in sublingual microvascular flow and capillary refill time. Microcirculatory abnormalities consisted in an increased number of small vessels with stopped, intermittent or slow flow. These changes seem minor, compared to those described in septic shock [6]. The proportion of unperfused vessels, however, represented a several times increase from normal values. Microvascular heterogeneity was greatly augmented, while perfusion velocity was decreased. These abnormalities might contribute to the development of multiple organ failure. Interestingly, decreases in vascular densities were correlated with increases in the capillary refill time, which is now considered a valuable goal of resuscitation in septic shock [8]. Our most striking finding was the increase in vascular density, which was correlated with the proportion of unperfused microvessels. Different mechanisms might underlie these findings. Patients severely affected with COVID-19 develop fever and hypoxemia. Therefore, hypoxia-induced capillary recruitment could be an explanation for the increased vascular density observed [9,10]. Besides, high metabolic activity and tissue hypoxia are recognized stimuli for vascular growth [11]. Another well-known trigger for angiogenesis is microthrombosis [12]. The association of pulmonary microthrombosis, angiogenesis and capillary proliferation has been described in patients with severe COVID-19 [2,13]. Our results suggest that this association is not only restricted to the lung but might also be a systemic phenomenon. Contrary to our results, the previous report found decreases in vascular density [5]. Since hypoxemia produces both capillary recruitment and angiogenesis, differences might be related to the higher compromise of pulmonary oxygenation in our patients (PaO2/FiO2, 122 ± 43 vs. 207 ± 88 mmHg). Our results showed that the diffusional determinants of microcirculatory oxygen availability–vascular densities–are increased whereas the convective components–microvascular flow index, proportion of perfused vessel and red blood cell velocity–are decreased. Besides, the presence of increased heterogeneity was a further challenge to tissue oxygenation. Since we only assessed microvascular perfusion, it is difficult to assert what the final impact on tissue oxygenation was. Main limitations of this study are the small sample size and the assessment of tissue perfusion on sublingual mucosa and skin only. Measurements were taken at a single time point, which does not rule out different findings in other stages of the illness. As the study was merely descriptive, the underlying mechanisms of the microvascular disorder are only speculative. Finally, we did not include a control group and microvascular variables were compared with referenced normal values.

Conclusions

Even though the microvascular disorder did not reach the characteristics of the widespread thrombotic microangiopathy described in the pulmonary bed, patients with severe COVID-19 pneumonia showed subtle but consistent alterations in sublingual microcirculation and skin perfusion.

Authors' contributions

AD had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. Concept and design: VSKE, JFGE, GF, AD. Acquisition, analysis, or interpretation of data: VSKE, JFGE, GF, EE, AD. Drafting of the manuscript: EE, AD. Critical revision of the manuscript for important intellectual content: VSKE, JFGE, GF, EE, AD. Statistical analysis: EE, AD.

Funding

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Availability of data and materials

The datasets generated during and/or analysed during the current study are available from the corresponding author on reasonable request.

Ethics approval and consent to participate

The respective institutional review boards approved this study and waived patient informed consent.

Consent for publication

Not applicable. Data are shown as mean ± SD. Normal values are related to reference 6.

Declaration of Competing Interest

The authors declare that they have no competing interests.
  12 in total

1.  Capillary recruitment in response to tissue hypoxia and its dependence on red blood cell deformability.

Authors:  K Parthasarathi; H H Lipowsky
Journal:  Am J Physiol       Date:  1999-12

2.  Quantitative assessment of the microcirculation in healthy volunteers and in patients with septic shock.

Authors:  Vanina S Kanoore Edul; Carolina Enrico; Bruno Laviolle; Alejandro Risso Vazquez; Can Ince; Arnaldo Dubin
Journal:  Crit Care Med       Date:  2012-05       Impact factor: 7.598

3.  The microcirculation image quality score: development and preliminary evaluation of a proposed approach to grading quality of image acquisition for bedside videomicroscopy.

Authors:  Michael J Massey; Ethan Larochelle; Gabriel Najarro; Adarsh Karmacharla; Ryan Arnold; Stephen Trzeciak; Derek C Angus; Nathan I Shapiro
Journal:  J Crit Care       Date:  2013-08-21       Impact factor: 3.425

4.  Recruitment of non-perfused sublingual capillaries increases microcirculatory oxygen extraction capacity throughout ascent to 7126 m.

Authors:  Matthias Peter Hilty; Tobias Michael Merz; Urs Hefti; Can Ince; Marco Maggiorini; Jacqueline Pichler Hefti
Journal:  J Physiol       Date:  2019-03-28       Impact factor: 5.182

5.  Effect of a Resuscitation Strategy Targeting Peripheral Perfusion Status vs Serum Lactate Levels on 28-Day Mortality Among Patients With Septic Shock: The ANDROMEDA-SHOCK Randomized Clinical Trial.

Authors:  Glenn Hernández; Gustavo A Ospina-Tascón; Lucas Petri Damiani; Elisa Estenssoro; Arnaldo Dubin; Javier Hurtado; Gilberto Friedman; Ricardo Castro; Leyla Alegría; Jean-Louis Teboul; Maurizio Cecconi; Giorgio Ferri; Manuel Jibaja; Ronald Pairumani; Paula Fernández; Diego Barahona; Vladimir Granda-Luna; Alexandre Biasi Cavalcanti; Jan Bakker; Glenn Hernández; Gustavo Ospina-Tascón; Lucas Petri Damiani; Elisa Estenssoro; Arnaldo Dubin; Javier Hurtado; Gilberto Friedman; Ricardo Castro; Leyla Alegría; Jean-Louis Teboul; Maurizio Cecconi; Maurizio Cecconi; Giorgio Ferri; Manuel Jibaja; Ronald Pairumani; Paula Fernández; Diego Barahona; Alexandre Biasi Cavalcanti; Jan Bakker; Glenn Hernández; Leyla Alegría; Giorgio Ferri; Nicolás Rodriguez; Patricia Holger; Natalia Soto; Mario Pozo; Jan Bakker; Deborah Cook; Jean-Louis Vincent; Andrew Rhodes; Bryan P Kavanagh; Phil Dellinger; Wim Rietdijk; David Carpio; Nicolás Pavéz; Elizabeth Henriquez; Sebastian Bravo; Emilio Daniel Valenzuela; Magdalena Vera; Jorge Dreyse; Vanessa Oviedo; Maria Alicia Cid; Macarena Larroulet; Edward Petruska; Claudio Sarabia; David Gallardo; Juan Eduardo Sanchez; Hugo González; José Miguel Arancibia; Alex Muñoz; Germán Ramirez; Florencia Aravena; Andrés Aquevedo; Fabián Zambrano; Milan Bozinovic; Felipe Valle; Manuel Ramirez; Victor Rossel; Pilar Muñoz; Carolina Ceballos; Christian Esveile; Cristian Carmona; Eva Candia; Daniela Mendoza; Aída Sanchez; Daniela Ponce; Daniela Ponce; Jaime Lastra; Bárbara Nahuelpán; Fabrizio Fasce; Cecilia Luengo; Nicolas Medel; Cesar Cortés; Luz Campassi; Paolo Rubatto; Nahime Horna; Mariano Furche; Juan Carlos Pendino; Lisandro Bettini; Carlos Lovesio; María Cecilia González; Jésica Rodruguez; Héctor Canales; Francisco Caminos; Cayetano Galletti; Estefanía Minoldo; Maria Jose Aramburu; Daniela Olmos; Nicolás Nin; Jordán Tenzi; Carlos Quiroga; Pablo Lacuesta; Agustín Gaudín; Richard Pais; Ana Silvestre; Germán Olivera; Gloria Rieppi; Dolores Berrutti; Marcelo Ochoa; Paul Cobos; Fernando Vintimilla; Vanessa Ramirez; Milton Tobar; Fernanda García; Fabricio Picoita; Nelson Remache; Vladimir Granda; Fernando Paredes; Eduardo Barzallo; Paul Garcés; Fausto Guerrero; Santiago Salazar; German Torres; Cristian Tana; José Calahorrano; Freddy Solis; Pedro Torres; Luís Herrera; Antonio Ornes; Verónica Peréz; Glenda Delgado; Alexei López; Eliana Espinosa; José Moreira; Blanca Salcedo; Ivonne Villacres; Jhonny Suing; Marco Lopez; Luis Gomez; Guillermo Toctaquiza; Mario Cadena Zapata; Milton Alonso Orazabal; Ruben Pardo Espejo; Jorge Jimenez; Alexander Calderón; Gustavo Paredes; José Luis Barberán; Tatiana Moya; Horacio Atehortua; Rodolfo Sabogal; Guillermo Ortiz; Antonio Lara; Fabio Sanchez; Alvaro Hernán Portilla; Humberto Dávila; Jorge Antonio Mora; Luis Eduardo Calderón; Ingrid Alvarez; Elena Escobar; Alejandro Bejarano; Luis Alfonso Bustamante; José Luis Aldana
Journal:  JAMA       Date:  2019-02-19       Impact factor: 56.272

6.  Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19.

Authors:  Maximilian Ackermann; Stijn E Verleden; Mark Kuehnel; Axel Haverich; Tobias Welte; Florian Laenger; Arno Vanstapel; Christopher Werlein; Helge Stark; Alexandar Tzankov; William W Li; Vincent W Li; Steven J Mentzer; Danny Jonigk
Journal:  N Engl J Med       Date:  2020-05-21       Impact factor: 91.245

Review 7.  Microvascular thrombosis: experimental and clinical implications.

Authors:  Monica A Bray; Sarah E Sartain; Jahnavi Gollamudi; Rolando E Rumbaut
Journal:  Transl Res       Date:  2020-05-23       Impact factor: 7.012

8.  Microvascular alterations in patients with SARS-COV-2 severe pneumonia.

Authors:  Elisa Damiani; Andrea Carsetti; Erika Casarotta; Claudia Scorcella; Roberta Domizi; Erica Adrario; Abele Donati
Journal:  Ann Intensive Care       Date:  2020-05-20       Impact factor: 6.925

9.  Angiopoietin-2 as a marker of endothelial activation is a good predictor factor for intensive care unit admission of COVID-19 patients.

Authors:  David M Smadja; Coralie L Guerin; Richard Chocron; Nader Yatim; Jeremy Boussier; Nicolas Gendron; Lina Khider; Jérôme Hadjadj; Guillaume Goudot; Benjamin Debuc; Philippe Juvin; Caroline Hauw-Berlemont; Jean-Loup Augy; Nicolas Peron; Emmanuel Messas; Benjamin Planquette; Olivier Sanchez; Bruno Charbit; Pascale Gaussem; Darragh Duffy; Benjamin Terrier; Tristan Mirault; Jean-Luc Diehl
Journal:  Angiogenesis       Date:  2020-05-27       Impact factor: 10.658

10.  Pulmonary and systemic involvement in COVID-19 patients assessed with ultrasound-guided minimally invasive autopsy.

Authors:  Amaro N Duarte-Neto; Renata A A Monteiro; Luiz F F da Silva; Denise M A C Malheiros; Ellen P de Oliveira; Jair Theodoro-Filho; João R R Pinho; Michele S Gomes-Gouvêa; Ana P M Salles; Ilka R S de Oliveira; Thais Mauad; Paulo H N Saldiva; Marisa Dolhnikoff
Journal:  Histopathology       Date:  2020-07-24       Impact factor: 7.778

View more
  12 in total

Review 1.  Protection by metformin against severe Covid-19: An in-depth mechanistic analysis.

Authors:  Nicolas Wiernsperger; Abdallah Al-Salameh; Bertrand Cariou; Jean-Daniel Lalau
Journal:  Diabetes Metab       Date:  2022-05-31       Impact factor: 8.254

Review 2.  The Potential of Thyroid Hormone Therapy in Severe COVID-19: Rationale and Preliminary Evidence.

Authors:  Iordanis Mourouzis; Vassiliki Apostolaki; Athanasios Trikas; Leonidas Kokkinos; Natassa Alexandrou; Maria Avdikou; Myrto Giannoulopoulou; Aimilia Vassi; Ioulia Tseti; Constantinos Pantos
Journal:  Int J Environ Res Public Health       Date:  2022-06-30       Impact factor: 4.614

3.  Veno-arterial thrombosis and microcirculation imaging in a patient with COVID-19.

Authors:  Sakir Akin; Daphne van Hooven; Can Ince; Tim Jansen
Journal:  Respir Med Case Rep       Date:  2021-05-11

Review 4.  Screening for venous thromboembolism in patients with COVID-19.

Authors:  Christophe Vandenbriele; Diana A Gorog
Journal:  J Thromb Thrombolysis       Date:  2021-05-21       Impact factor: 2.300

5.  Case Report: Sublingual Microcirculatory Alterations in a Covid-19 Patient With Subcutaneous Emphysema, Venous Thrombosis, and Pneumomediastinum.

Authors:  Sanjeev Grewal; Brita Harjo; Güclü Aykut; Bülent Ergin; Ralph Nowitzky; Can Ince; Sakir Akin
Journal:  Front Med (Lausanne)       Date:  2021-01-28

6.  Microvascular dysfunction in pediatric patients with SARS-COV-2 pneumonia: report of three severe cases.

Authors:  G Bottari; E Damiani; V Confalone; C Scorcella; E Casarotta; C Gandolfo; F Stoppa; C Cecchetti; A Donati
Journal:  Microvasc Res       Date:  2022-01-10       Impact factor: 3.514

7.  Microvascular Dysfunction in Patients with Critical Covid-19, a Pilot Study.

Authors:  Sara Tehrani; Patrik Gille-Johnson
Journal:  Shock       Date:  2021-12-01       Impact factor: 3.533

Review 8.  Covid-19 and Liver Injury: Role of Inflammatory Endotheliopathy, Platelet Dysfunction, and Thrombosis.

Authors:  Matthew J McConnell; Reiichiro Kondo; Nao Kawaguchi; Yasuko Iwakiri
Journal:  Hepatol Commun       Date:  2021-11-10

Review 9.  COVID-19 and thrombosis: The role of hemodynamics.

Authors:  Sudeep Sastry; Federica Cuomo; Jayaveera Muthusamy
Journal:  Thromb Res       Date:  2022-02-23       Impact factor: 3.944

Review 10.  COVID-19 is a systemic vascular hemopathy: insight for mechanistic and clinical aspects.

Authors:  David M Smadja; Steven J Mentzer; Michaela Fontenay; Mike A Laffan; Maximilian Ackermann; Julie Helms; Danny Jonigk; Richard Chocron; Gerald B Pier; Nicolas Gendron; Stephanie Pons; Jean-Luc Diehl; Coert Margadant; Coralie Guerin; Elisabeth J M Huijbers; Aurélien Philippe; Nicolas Chapuis; Patrycja Nowak-Sliwinska; Christian Karagiannidis; Olivier Sanchez; Philipp Kümpers; David Skurnik; Anna M Randi; Arjan W Griffioen
Journal:  Angiogenesis       Date:  2021-06-28       Impact factor: 9.596

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.